GS
GILD icon

GTS Securities’s Gilead Sciences GILD Stock Holding History

GTS Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Sell
4,608
-2,469
-35% -$325K 0.01% 646
2026
Q1 		$986K Sell
7,077
-7,104
-50% -$995K 0.03% 405
2025
Q4 		$1.74M Sell
14,181
-11,345
-44% -$1.38M 0.06% 255
2025
Q3 		$2.83M Buy
25,526
+19,038
+293% +$2.16M 0.11% 151
2025
Q2 		$719K Sell
6,488
-35
-0.5% -$3.73K 0.03% 494
2025
Q1 		$731K Sell
6,523
-7,354
-53% -$759K 0.03% 520
2024
Q4 		$1.28M Sell
13,877
-82,807
-86% -$7.46M 0.06% 257
2024
Q3 		$8.11M Buy
96,684
+16,334
+20% +$1.25M 0.02% 606
2024
Q2 		$5.51M Buy
80,350
+48,975
+156% +$3.27M 0.01% 804
2024
Q1 		$2.3M Buy
31,375
+7,102
+29% +$546K ﹤0.01% 1390
2023
Q4 		$1.97M Sell
24,273
-89,254
-79% -$6.95M ﹤0.01% 1668
2023
Q3 		$8.51M Buy
113,527
+15,601
+16% +$1.2M 0.02% 667
2023
Q2 		$7.55M Buy
+97,926
New +$7.81M 0.24% 79

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GTS Securities's GILD Position: Q2 2026 in Review

GTS Securities reduced its Gilead Sciences (GILD) stake by 35% in Q2 2026, selling an estimated $325K and leaving 4,608 shares worth $582K. The position accounts for 0.01% of the portfolio, ranked #646.

GTS Securities first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.51M in Q3 2023. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GTS Securities held 4,608 shares of Gilead Sciences worth $582K as of Q2 2026.
  • GTS Securities sold 2,469 Gilead Sciences shares in Q2 2026, an estimated $325K.
  • Gilead Sciences made up 0.01% of GTS Securities's portfolio in Q2 2026, its #646 holding.
  • GTS Securities first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
  • GTS Securities's Gilead Sciences position peaked at $8.51M in Q3 2023.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.